Melissa Rewolinski
Direktor/Vorstandsmitglied bei ARBUTUS BIOPHARMA CORPORATION
Vermögen: - $ am 31.05.2024
Aktive Positionen von Melissa Rewolinski
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ARBUTUS BIOPHARMA CORPORATION | Direktor/Vorstandsmitglied | 12.07.2023 | - |
Independent Dir/Board Member | 12.07.2023 | - | |
Mvr Consulting, Inc. | Gründer | 01.08.2018 | - |
Corporate Officer/Principal | 01.08.2018 | - | |
American Type Culture Collection
American Type Culture Collection BiotechnologyHealth Technology American Type Culture Collection operates as a global biological materials resource and standards organization offering a collection of products and services. Its services include production and characterization, testing, biorepository, and deposit. The company was founded in 1925 and is headquartered in Manassas, VA. | Direktor/Vorstandsmitglied | 01.09.2021 | - |
Karriereverlauf von Melissa Rewolinski
Ehemalige bekannte Positionen von Melissa Rewolinski
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
LANNETT COMPANY, INC. | Direktor/Vorstandsmitglied | 01.07.2019 | 16.06.2023 |
Independent Dir/Board Member | 01.07.2019 | 16.06.2023 | |
INTERCEPT PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.04.2008 | 01.07.2018 |
Amira Pharmaceuticals, Inc.
Amira Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 2005 and headquartered in San Diego, Amira Pharmaceuticals is a small molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory and fibrotic diseases. Amira combines the rigor of a big pharmaceutical company with the ingenuity and energy of a small company, creating an environment for efficient development of novel compounds and effective pre-clinical and clinical program decisions. The firm's team is building on unparalleled insights into bioactive lipid pathways and complex signaling processes controlling many conditions including asthma, chronic obstructive pulmonary disease, cardiovascular and various fibrotic diseases. Amira has a partnership with GlaxoSmithKline for the development of FLAP (5-lipoxygenase activating protein) inhibitors in respiratory and cardiovascular disease. | Corporate Officer/Principal | 01.02.2006 | 01.04.2008 |
Ausbildung von Melissa Rewolinski
Rice University | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Operativ
Director/Board Member | 3 |
Corporate Officer/Principal | 3 |
Independent Dir/Board Member | 2 |
Sektoral
Health Technology | 6 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
LANNETT COMPANY, INC. | Health Technology |
INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
ARBUTUS BIOPHARMA CORPORATION | Health Technology |
Private Unternehmen | 3 |
---|---|
Amira Pharmaceuticals, Inc.
Amira Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 2005 and headquartered in San Diego, Amira Pharmaceuticals is a small molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory and fibrotic diseases. Amira combines the rigor of a big pharmaceutical company with the ingenuity and energy of a small company, creating an environment for efficient development of novel compounds and effective pre-clinical and clinical program decisions. The firm's team is building on unparalleled insights into bioactive lipid pathways and complex signaling processes controlling many conditions including asthma, chronic obstructive pulmonary disease, cardiovascular and various fibrotic diseases. Amira has a partnership with GlaxoSmithKline for the development of FLAP (5-lipoxygenase activating protein) inhibitors in respiratory and cardiovascular disease. | Health Technology |
American Type Culture Collection
American Type Culture Collection BiotechnologyHealth Technology American Type Culture Collection operates as a global biological materials resource and standards organization offering a collection of products and services. Its services include production and characterization, testing, biorepository, and deposit. The company was founded in 1925 and is headquartered in Manassas, VA. | Health Technology |
Mvr Consulting, Inc. |
- Börse
- Insiders
- Melissa Rewolinski
- Erfahrung